SCHEMBL4515067

SCHEMBL4515067

CCOC(=O)C1CCCN(CCCO)C1

nearest known ligand 0.66

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.59
KDM4E B2RXH2 7/20 0.59
HTR7 P34969 2/20 0.56
HTR1A P08908 1/20 0.56
DRD2 P14416 1/20 0.56
HTR2A P28223 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
L3MBTL1 Q9Y468 2/20 0.53
ATM Q13315 1/20 0.53
MAPK1 P28482 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
MAPT P10636 1/20 0.53
GAA P10253 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4514426 0.91 ALDH1A1 (0.62) ALDH1A1KDM4ESMN1; SMN2TDP1L3MBTL1
SCHEMBL7925245 0.91 ALDH1A1 (0.62) ALDH1A1KDM4ESMN1; SMN2TDP1L3MBTL1
SCHEMBL4523590 0.91 ALDH1A1 (0.56) ALDH1A1KDM4EHTR7HTR1ADRD2
SCHEMBL9342470 0.90 KDM4E (0.60) ALDH1A1KDM4EHTR7HTR1ADRD2
SCHEMBL4506995 0.89 ALDH1A1 (0.59) ALDH1A1KDM4EHTR7HTR1ADRD2
SCHEMBL4514567 0.87 KDM4E (0.59) ALDH1A1KDM4EHTR7HTR1ADRD2
SCHEMBL20794235 0.87 BCHE (0.68) ALDH1A1KDM4EHTR7HTR1ADRD2
SCHEMBL4500076 0.87 ALDH1A1 (0.58) ALDH1A1KDM4ESMN1; SMN2TDP1L3MBTL1
SCHEMBL7923817 0.87 ALDH1A1 (0.58) ALDH1A1KDM4EHTR7HTR1ADRD2
SCHEMBL4513801 0.87 ALDH1A1 (0.63) ALDH1A1KDM4ESMN1; SMN2TDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260001838-A1 NANOMATERIALS GUIDE THERAPEUTICS LLC (US) 2026-01-01 US disclosed
US-12435035-B2 Nanomaterials GUIDE THERAPEUTICS, LLC (US) 2025-10-07 US disclosed
CN-119684140-A Nanomaterial for the preparation of a nanoparticle 盖德治疗有限责任公司 2025-03-25 CN disclosed
CN-115175894-B Nanomaterial for the preparation of a nanoparticle 盖德治疗有限责任公司 2024-09-06 CN disclosed
EP-4103542-A1 NANOMATERIALS Guide Therapeutics, LLC (US) 2022-12-21 EP disclosed
CN-115175894-A Nano material 盖德治疗有限责任公司 2022-10-11 CN disclosed
US-20210230112-A1 NANOMATERIALS GUIDE THERAPEUTICS, LLC 2021-07-29 US disclosed
US-20210230112-A1 NANOMATERIALS GUIDE THERAPEUTICS, LLC 2021-07-29 US disclosed
US-20090258883-A1 1H-Indole-Pyridinecarboxamide and 1H-Indole-Piperidinecarboxamide Compounds LES LABORATOIRES SERVIER (FR) 2009-10-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210230112-A1 NANOMATERIALS NPC1, NPC1L1, FABP1 ALDH1A1 984/4885KDM4E 4299/4885HTR7 4210/4885
US-20260001838-A1 NANOMATERIALS SLC10A1, NPC1L1, FABP1 ALDH1A1 619/4885KDM4E 1939/4885HTR7 4390/4885
US-12435035-B2 Nanomaterials NPC1, NPC1L1, FABP1 ALDH1A1 984/4885KDM4E 4299/4885HTR7 4210/4885
US-20090258883-A1 1H-Indole-Pyridinecarboxamide and 1H-Indole-Piperidinecarboxamide Compounds IDO1, AHR, IDO2 ALDH1A1 370/4885KDM4E 2039/4885HTR7 194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.